Mutations in the KRAS gene are the primary driver of pancreatic cancer. A new class of drugs known as KRAS inhibitors is showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment.
New discovery suggests opportunity to improve effectiveness of KRAS inhibitors against pancreatic cancer retrieved 11 July 2024 from https://medicalxpress.com/news/2024-07-discovery-opportunity-effectiveness-kras-inhibitors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New technique reveals earliest signs of genetic mutationsMutations are changes in the molecular 'letters' that make up the DNA code, the blueprint for all living cells. Some of these changes can have little effect, but others can lead to diseases, including cancer.
Read more »
New class of cancer mutations discovered in so-called 'junk' DNAUsing artificial intelligence, Garvan Institute researchers have found potential cancer drivers hidden in so-called 'junk' regions of DNA, opening up possibilities for a new approach to diagnosis and treatment.
Read more »
New name, new uniform and new principal at Telford secondary schoolA Telford secondary school has announced the start of an ambitious new era – with a new name, new uniform, and a new principal.
Read more »
How calcium channel mutations lead to cognitive dysfunctionA new study from Yale School of Medicine has shown that the neurons that generate higher cognition, and are a target of pathology in Alzheimer's disease and mental disorders such as schizophrenia, express an enrichment of calcium-related proteins that helps to explain their vulnerability to disease.
Read more »
Researchers more effectively study mutations that cause heart disease by putting cells through their pacesUsing animals to study heart disease doesn't always translate well to human health outcomes, and human heart cells available for research don't work outside the human body.
Read more »
Nf1 gene mutations disrupt brain cell plasticity and motor learning in miceNeurogenetic disorders, such as neurofibromatosis type 1 (NF1), are diseases caused by a defect in one or more genes, which can sometimes result in cognitive and motor impairments.
Read more »